Process and Analytical Development of Drug-Fc Conjugates (DFCs)
Time: 11:30 am
day: Day Two
Details:
- Evaluate Cidara Therapeutics’ DFCs developments to address serious diseases
- Compare and expand upon the strengths of small molecules and antibody therapeutics using the uniquely tunable DFCs platform
- Address the unique challenges associated with each DFCs product development, considering disease area, dose regimen, and properties
